Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XeriSol Glucagon in Dual-Hormone Artificial Pancreas for Type 1 Diabetes
NCT03424044Phase 1Completed
- Sponsor
- Oregon Health & Science University
- Start
- Mar 2018
- Primary completion
- May 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by Oregon Health & Science University. Started Mar 2018; status: completed.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03424044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03424044.